Providence Cancer Institute of Oregon

Providence Cancer Institute of Oregon is a premier oncology center and research facility located in Portland, Oregon, dedicated to the development of innovative cancer immunotherapies. It operates the Earle A. Chiles Research Institute, a world-class laboratory focused on tumor immunology and translational research. The institute is a leader in clinical trials for adoptive cell therapy, including tumor-infiltrating lymphocytes (TILs) and engineered T-cells. As part of the Providence Health & Services network, it provides comprehensive cancer care while maintaining a robust pipeline of investigator-initiated studies. The facility features advanced manufacturing capabilities, including a GMP-compliant cell processing laboratory for producing personalized cell therapies. Its research programs are particularly noted for their contributions to the understanding of immune checkpoint inhibitors and cancer vaccines.